Presentation TCT 2013 Device and Clinical Trial Update: Cordis Renal Denervation Approach Presenter: Marc Sapoval October 27, 2013 REGISTER for free or LOG IN to view this content Renovascular Presentation TCT 2013 Up Next Presentation TCT 2013 Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation? Presenter: Peter Fitzgerald October 27, 2013 More slides + Presentation TCT 2013 Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR Presenter: Neil Moat October 27, 2013 Presentation TCT 2013 Setting up a Thriving Clinical Research Program: The Basics and More Presenter: David Cox October 27, 2013 We Recommend
Presentation TCT 2013 Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation? Presenter: Peter Fitzgerald October 27, 2013
Presentation TCT 2013 Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR Presenter: Neil Moat October 27, 2013
Presentation TCT 2013 Setting up a Thriving Clinical Research Program: The Basics and More Presenter: David Cox October 27, 2013